H

Hepion Pharmaceuticals
D

HEPA

0.71440
USD
0.03
(4.75%)
مغلق
حجم التداول
0
الربح لكل سهم
-11
العائد الربحي
-
P/E
-0
حجم السوق
4,142,896
أصول ذات صلة
الأخبار

العنوان: Hepion Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan-cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.